The global enteral feeding formulas market is projected to reach USD 8.2 billion by 2027 from USD 5.2 billion in 2022, growing at a CAGR of 9.5% during the forecast period. Growth in this market is largely driven by factors such as the benefits and cost-effectiveness of enteral nutrition over parenteral nutrition, rise in preterm births, growing demand for enteral feeding in the home care sector, and rapid growth in the geriatric population and subsequent growth in the prevalence of chronic diseases. On the other hand, complications involved with enteral feeding and lack of patient awareness are expected to hinder the market growth.